Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

A new scientific statement from the American College of Cardiology (ACC) has pulled together recommendations on antiplatelet medication use across primary and secondary prevention settings. These ...

Good morning, everyone, and welcome to Part 1 of Arrowhead Pharmaceuticals' 2026 Summer Series of R&D webinars. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be ...

While dual antiplatelet therapy (DAPT) effectively reduces thrombotic and ischaemic complications following percutaneous ...

A 70-year-old woman presents to the ED with chest pain, shortness of breath and diaphoresis. Her symptoms began about 24 ...

SGLT2 Inhibitors Cut Kidney Events in Nephrotic Proteinuria In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse kidney events ...

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS ...

Interventions using wearables or smartphones to track daily movement were shown to significantly boost physical activity among patients with a history of heart disease and stroke, researchers reported ...

Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western ...

An opt-out system seems to help, but there’s more work to do to meet performance goals endorsed by the AHA and ACC.

Nashville welcomed SHM Converge 2026, and with it one of the conference’s most anticipated annual traditions: the Updates in Hospital Medicine session. Kencee Graves, MD, FHM, clinical professor of ...